Pharma Focus America

Pharma Focus America Welcome to Pharma focus America! We bring you the latest insights, innovations, and news from the world of pharmaceuticals. Ltd..

Join our community to stay updated and engage with industry experts! https://www.linkedin.com/company/pharmafocusamerica/ About Pharma Focus America:
Pharma Focus Aerica is a half yearly publication from Ochre Media Pvt. It is the leading pharma title in print and digital versions serving the information needs of key executives from the world’s leading pharmaceutical companies. Pharma Focus America covers important issues and trends shaping the future of the pharma industry across America and rest of the world. Pharma Focus America offers . . .
• Dedicated, reliable and accurate coverage of the industry’s progress and
• Incisive analysis to help its readers make informed decisions to stay ahead of the competition. The magazine provides cutting-edge and futuristic content on the pharma industry. The issues are broadly categorized into various sections:
• Strategy
• Research and Development
• Manufacturing
• Clinical Trials
• Information Technology

The one-stop pharma destination www.pharmafocusamerica.com features complete content from the Pharma Focus America magazine. Also find the latest pharma news, press releases, pharma industry reports, interviews, trends and pharma events updated on a daily basis. The magazine is supplemented by the monthly e-Newsletter: Verticaltalk Pharma. The readership
The magazine’s readership includes the top C-level executives, senior industry executives, and key decision makers from the pharma industry in charge of spending. With a special focus on America, Pharma Focus America reaches out to the key industry leaders across America, Europe and the Asia.

Safer gene editing is becoming a reality. 𝐀𝐧𝐭𝐢-𝐂𝐑𝐈𝐒𝐏𝐑 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐬 act like biological safety switches, giving scientists co...
04/12/2025

Safer gene editing is becoming a reality. 𝐀𝐧𝐭𝐢-𝐂𝐑𝐈𝐒𝐏𝐑 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐬 act like biological safety switches, giving scientists control over when and where CRISPR is active.

𝐈𝐧 𝐚𝐧 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐚𝐮𝐭𝐡𝐨𝐫𝐞𝐝 𝐛𝐲 𝐅𝐚𝐭𝐞𝐦𝐞𝐡 𝐀𝐤𝐡𝐨𝐨𝐧𝐝𝐢, 𝐌𝐒𝐜, 𝐥𝐞𝐚𝐫𝐧 𝐡𝐨𝐰 𝐭𝐡𝐢𝐬 𝐛𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐬 𝐬𝐮𝐩𝐩𝐨𝐫𝐭𝐢𝐧𝐠:
• Safer CAR-T & immune-cell therapy
• More precise stem-cell editing
• Controlled AAV-based CRISPR delivery
• Reduced risk of off-target mutations in base/prime editing

A more secure path to CRISPR-powered medicine is emerging—and the science behind it is remarkable.

🔗 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 → https://www.pharmafocusamerica.com/articles/anti-crispr-proteins-a-biological-safety-switch

AI is changing the way medicines are built—from molecule selection to clinical trials. But how do we protect these groun...
03/12/2025

AI is changing the way medicines are built—from molecule selection to clinical trials. But how do we protect these groundbreaking innovations under today’s patent laws?

Industry expert 𝐏𝐫𝐨𝐟. (𝐃𝐫.) 𝐀𝐦𝐫𝐢𝐬𝐡 𝐂𝐡𝐚𝐧𝐝𝐫𝐚 (𝐌𝐚𝐧𝐚𝐠𝐢𝐧𝐠 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫, 𝐋𝐞𝐱𝐠𝐢𝐧 𝐈𝐏 𝐋𝐋𝐏) breaks down the most pressing challenges in AI-based drug discovery, including patentability barriers, inventorship clarity, ethical considerations, and different patent rules around the world.

A must-read for pharma researchers, IP professionals, and innovation-driven organisations.

📌 𝐅𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐧𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.pharmafocusamerica.com/articles/ai-drug-discovery-ip-strategy-navigating-patent-challenges

Regulatory change in the 𝐔.𝐒. 𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 is reshaping how medicines reach patients—from faster FDA approvals to str...
02/12/2025

Regulatory change in the 𝐔.𝐒. 𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 is reshaping how medicines reach patients—from faster FDA approvals to stronger supply chain safety, fairer pricing models, and heightened focus on patient involvement.

Pharma companies that stay agile and informed not only meet compliance goals but build a safer, more transparent healthcare ecosystem for everyone.

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐞𝐞 𝐡𝐨𝐰 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬 𝐚𝐫𝐞 𝐩𝐫𝐞𝐩𝐚𝐫𝐢𝐧𝐠 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐰𝐚𝐯𝐞? 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞.
🔗https://www.pharmafocusamerica.com/articles/navigating-the-regulatory-landscape-impact-of-recent-and-upcoming-changes-on-pharma-businesses-in-the-united-states

𝐏𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 organizations are navigating some of the most complex regulatory environments ever. That’s why more c...
01/12/2025

𝐏𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 organizations are navigating some of the most complex regulatory environments ever. That’s why more companies are partnering with outsourced regulatory experts to streamline submissions, increase global compliance, and get therapies to market faster—with accuracy and confidence.

The right outsourcing strategy supports everything from documentation and audits to lifecycle management, digital submissions, and post-market reporting.

Ready to improve efficiency and reduce delays in regulatory submissions?

𝐋𝐞𝐚𝐫𝐧 𝐡𝐨𝐰 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐨𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐢𝐧𝐠 𝐢𝐬 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞: 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞
https://www.pharmafocusamerica.com/articles/regulatory-affairs-outsourcing

The 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 depends on pushing boundaries — and antibody discovery for complex membrane targets like GPCRs i...
28/11/2025

The 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐛𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 depends on pushing boundaries — and antibody discovery for complex membrane targets like GPCRs is finally advancing in ways that matter to researchers and scientists everywhere.

Join us for a webinar featuring Dr. Jens Frauenfeld and Dr. Paul Royle as they share breakthrough approaches to stabilizing GPCRs and generating high-affinity antibodies using next-gen phage display tools. Whether you're working in drug discovery, structural biology, or therapeutic development, this session offers insights you won’t want to miss.

📅 2 December | ⏱ 8AM PST / 11AM EST / 4PM GMT / 5PM CET

🔗 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞 → https://industry.pharmafocusamerica.com/clientemailblast/1763961931-Bio-Rad.html

The world of 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 in the United States is changing quickly—and it’s reshaping how companies connect ...
27/11/2025

The world of 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭𝐢𝐧𝐠 in the United States is changing quickly—and it’s reshaping how companies connect with patients and healthcare professionals. From digital-first communication and trusted educational content to transparent DTC campaigns and strong healthcare partnerships, today’s strategies are built around improving real-world outcomes.

By focusing on value, empathy, and compliance, pharma leaders are creating meaningful impact within the healthcare community.

🌐 Want to understand the marketing trends shaping the future of American pharma?

➡️ 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐧𝐝 𝐬𝐭𝐚𝐲 𝐢𝐧𝐟𝐨𝐫𝐦𝐞𝐝: https://www.pharmafocusamerica.com/articles/evolving-trends-and-strategies-in-pharmaceutical-marketing-focus-on-the-american-market

A big moment for the gastric cancer communityImfinzi + FLOT has officially been approved in the US as the first perioper...
26/11/2025

A big moment for the gastric cancer community

Imfinzi + FLOT has officially been approved in the US as the first perioperative immunotherapy for early gastric and GEJ cancers. Clinical results from the Phase III MATTERHORN trial showed meaningful improvements in survival and reduced risk of disease recurrence—bringing new hope to patients and families affected by these high-burden cancers.

This advancement marks a new chapter in curative-intent treatment and highlights the growing importance of immunotherapy in earlier-stage disease.

➡️ If you work in oncology, pharma, research, or clinical care, follow our platform for the most important industry breakthroughs and regulatory updates: https://www.pharmafocusamerica.com/pharma-exclusives/press-releases/imfinzi-approved-in-the-us-as-first-and-only-perioperative

𝐆𝐏𝐂𝐑𝐬 are some of the toughest targets in antibody research—and the scientific community is coming together to solve tha...
26/11/2025

𝐆𝐏𝐂𝐑𝐬 are some of the toughest targets in antibody research—and the scientific community is coming together to solve that challenge! ✨

Join a powerful session led by Dr. Jens Frauenfeld and Dr. Paul Royle as they share groundbreaking work on stabilizing membrane proteins and applying phage display to generate high-affinity antibodies for hard-to-hit targets.

𝐖𝐡𝐚𝐭 𝐲𝐨𝐮’𝐥𝐥 𝐥𝐞𝐚𝐫𝐧:
🔹 Why GPCRs matter for modern therapeutics
🔹 Membrane stabilization tech for better research outcomes
🔹 Strategies that preserve critical epitopes & reduce off-target binding

📅 December 2 | 8 AM PST / 11 AM EST / 4 PM GMT / 5 PM CET

👉 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰 𝐚𝐧𝐝 𝐛𝐞 𝐩𝐚𝐫𝐭 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧: https://industry.pharmafocusamerica.com/clientemailblast/1763961931-Bio-Rad.html

AstraZeneca is making a major move in the U.S. biotech landscape with a $2 billion investment in Maryland!This expansion...
25/11/2025

AstraZeneca is making a major move in the U.S. biotech landscape with a $2 billion investment in Maryland!

This expansion will:
✔ Nearly double biologics production
✔ Build a new clinical manufacturing facility in Gaithersburg
✔ Support 2,600 jobs, including 300 high-skill positions

Both sites will integrate AI, automation, and sustainable technologies—supporting future-ready pharma manufacturing and improving access to innovative therapies.

Stay connected with the latest pharma developments and insights on Pharma Focus America:
https://www.pharmafocusamerica.com/pharma-exclusives/press-releases/astrazeneca-plans-2-billion-manufacturing-investment

The 𝐅𝐃𝐀 has made key regulatory updates that are transforming the future of drug approvals, clinical trials, and compli...
25/11/2025

The 𝐅𝐃𝐀 has made key regulatory updates that are transforming the future of drug approvals, clinical trials, and compliance expectations—and the pharma industry is already feeling the impact.

From priority review programs to accelerated approvals and digital evidence submissions, research teams and decision-makers must rethink how they plan, submit, and validate regulatory milestones.

Staying informed isn’t just helpful—it keeps innovation moving and patients connected to the therapies they need sooner.

👉 𝐒𝐭𝐚𝐲 𝐚𝐡𝐞𝐚𝐝 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐡𝐚𝐧𝐠𝐞𝐬. 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐬𝐢𝐭𝐞 𝐟𝐨𝐫 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬, 𝐚𝐧𝐝 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲-𝐟𝐨𝐜𝐮𝐬𝐞𝐝 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞 𝐭𝐡𝐚𝐭 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐚𝐬𝐭𝐞𝐫, 𝐬𝐦𝐚𝐫𝐭𝐞𝐫 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐩𝐚𝐭𝐡𝐰𝐚𝐲𝐬.
https://www.pharmafocusamerica.com/articles/fda-regulatory-updates-drug-approval-process

The pharma world moves fast—and staying informed shouldn’t be complicated. 🚀Our latest 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 i...
24/11/2025

The pharma world moves fast—and staying informed shouldn’t be complicated. 🚀

Our latest 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐨𝐜𝐮𝐬 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 is now live and filled with expert interviews, industry news, research insights, technology trends, events, podcasts, and more!

Whether you're a scientist, decision-maker, researcher, or healthcare innovator—there's something valuable for you.

👉 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐛𝐞 𝐧𝐨𝐰 𝐚𝐧𝐝 𝐡𝐞𝐥𝐩 𝐬𝐩𝐫𝐞𝐚𝐝 𝐭𝐡𝐞 𝐰𝐨𝐫𝐝 𝐛𝐲 𝐬𝐡𝐚𝐫𝐢𝐧𝐠 𝐢𝐭 𝐰𝐢𝐭𝐡𝐢𝐧 𝐲𝐨𝐮𝐫 𝐜𝐨𝐦𝐦𝐮𝐧𝐢𝐭𝐲: https://www.pharmafocusamerica.com/subscribe

https://industry.pharmafocusamerica.com/e-newsletters/1763455959-Pharma-Focus-America-Nov-25.html

𝐁𝐢𝐠 𝐧𝐞𝐰𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐰𝐨𝐫𝐥𝐝 𝐨𝐟 𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐛𝐢𝐨𝐭𝐞𝐜𝐡—𝐀𝐬𝐭𝐫𝐚𝐙𝐞𝐧𝐞𝐜𝐚 𝐢𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 $𝟐 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝐌𝐚𝐫𝐲𝐥𝐚𝐧𝐝!This expansion will boost bi...
24/11/2025

𝐁𝐢𝐠 𝐧𝐞𝐰𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐰𝐨𝐫𝐥𝐝 𝐨𝐟 𝐩𝐡𝐚𝐫𝐦𝐚 𝐚𝐧𝐝 𝐛𝐢𝐨𝐭𝐞𝐜𝐡—𝐀𝐬𝐭𝐫𝐚𝐙𝐞𝐧𝐞𝐜𝐚 𝐢𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐢𝐧𝐠 $𝟐 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝐌𝐚𝐫𝐲𝐥𝐚𝐧𝐝!

This expansion will boost biologics production, build a new clinical manufacturing facility, and support 2,600 jobs, including 300 highly skilled positions. With AI-powered operations and a strong focus on sustainability, this development strengthens the U.S. healthcare ecosystem and accelerates the availability of innovative treatments.

Initiatives like this continue shaping the future of medicine, research, and patient care.

👉 𝐒𝐭𝐚𝐲 𝐢𝐧𝐟𝐨𝐫𝐦𝐞𝐝 𝐰𝐢𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐩𝐡𝐚𝐫𝐦𝐚 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐮𝐩𝐝𝐚𝐭𝐞𝐬 𝐨𝐧 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞.
https://www.pharmafocusamerica.com/pharma-exclusives/press-releases/astrazeneca-plans-2-billion-manufacturing-investment

Address

111, 112 First Floor, Block 2, White House
Hyderabad
500016

Website

Alerts

Be the first to know and let us send you an email when Pharma Focus America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category